Most cited papers from Xuzhou Central Hospital

Xuzhou Central Hospital

What are the most cited papers from Xuzhou Central Hospital?

The most cited paper from Xuzhou Central Hospital is "CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea" (R. Doug McEvoy et al., 2016), with 2,096 citations. Next come "Role of oxidative stress in Alzheimer's disease" (1,036) and "Role of neuroinflammation in neurodegenerative diseases (Review)" (948).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 142 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea R. Doug McEvoy et al. · New England Journal of Medicine	28 Aug 2016	2,096
2	Role of oxidative stress in Alzheimer's disease Wenjuan Huang, Xia Zhang, Weiwei Chen · Biomedical Reports Open access	15 Mar 2016	1,036
3	Role of neuroinflammation in neurodegenerative diseases (Review) Weiwei Chen, Xia Zhang, Wenjuan Huang · Molecular Medicine Reports Open access	29 Feb 2016	948
4	Breast Cancer: Epidemiology and Etiology Ziqi Tao, Aimin Shi, Cuntao Lu et al. · Cell Biochemistry and Biophysics	27 Dec 2014	713
5	Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial Xinfeng Liu et al. · The Lancet Neurology 143 authors	9 Dec 2019	657
6	Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial Zixian Wang et al. · Cancer Cell Open access	Mar 2022	592
7	Effect of Endovascular Treatment Alone vs Intravenous Alteplase Plus Endovascular Treatment on Functional Independence in Patients With Acute Ischemic Stroke Wenjie Zi et al. · JAMA Open access	19 Jan 2021	538
8	Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Mohsen Naghavi et al. · The Lancet Open access2,463 authors	Oct 2025	500
9	Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer Ying Cheng et al. · JAMA Open access109 authors	27 Sep 2022	497
10	Myocardial Infarction: Symptoms and Treatments Lei Lü, Min Liu, Rongrong Sun et al. · Cell Biochemistry and Biophysics	31 Jan 2015	484
11	m6A-dependent glycolysis enhances colorectal cancer progression Chaoqin Shen, Baoqin Xuan, Tingting Yan et al. · Molecular Cancer Open access	3 Apr 2020	470
12	Obesity and hypertension Shu-Zhong Jiang, Wen Lu, Xue-Feng Zong et al. · Experimental and Therapeutic Medicine Open access	6 Sep 2016	460
13	Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke Craig S. Anderson et al. · New England Journal of Medicine Open access	10 May 2016	446
14	Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer Jin Li et al. · JAMA Open access	26 Jun 2018	415
15	Meta-analysis identifies common variants associated with body mass index in east Asians Wanqing Wen et al. · Nature Genetics Open access	19 Feb 2012	405
16	Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study) Yifei Zhang et al. · Nature Communications Open access	6 Oct 2020	399
17	H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma Erbao Zhang, Liang Han, Dandan Yin et al. · Nucleic Acids Research Open access	29 Nov 2016	377
18	A genomic and epigenomic atlas of prostate cancer in Asian populations Jing Li et al. · Nature	25 Mar 2020	368
19	Assessment of Endovascular Treatment for Acute Basilar Artery Occlusion via a Nationwide Prospective Registry Writing Group for the BASILAR Group et al. · JAMA Neurology Open access	21 Feb 2020	363
20	Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a Erbao Zhang, Rong Kong, Dandan Yin et al. · Oncotarget Open access	16 Apr 2014	355
21	Multiple sclerosis: Pathology, diagnosis and treatments Wenjuan Huang, Weiwei Chen, Xia Zhang · Experimental and Therapeutic Medicine Open access	28 Apr 2017	354
22	2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules: the C-TIRADS Jianqiao Zhou et al. · Endocrine 239 authors	21 Aug 2020	348
23	Epidemiological Perspectives of Diabetes Ziqi Tao, Aimin Shi, Jing Zhao · Cell Biochemistry and Biophysics	24 Feb 2015	341
24	Congenital Heart Disease: Causes, Diagnosis, Symptoms, and Treatments Rongrong Sun, Min Liu, Lei Lu et al. · Cell Biochemistry and Biophysics	31 Jan 2015	304
25	A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1 Erbao Zhang, Xuezhi He, Chongguo Zhang et al. · Genome biology Open access	4 Oct 2018	300
26	Safety and Efficacy of Atorvastatin for Chronic Subdural Hematoma in Chinese Patients Rongcai Jiang et al. · JAMA Neurology Open access	30 Jul 2018	294
27	A Randomized Clinical Study Comparing Double Kissing Crush With Provisional Stenting for Treatment of Coronary Bifurcation Lesions Shao‐Liang Chen, Teguh Iman Santoso, Junjie Zhang et al. · Journal of the American College of Cardiology Open access	Feb 2011	287
28	Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial Craig S Anderson et al. · The Lancet Open access652 authors	9 Feb 2019	279
29	Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts Lijun Ning, Yilu Zhou, Han Lin Sun et al. · Nature Communications Open access	6 Nov 2023	277
30	Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade Kun Pang, Zhenduo Shi, Liuya Wei et al. · Drug Resistance Updates	30 Nov 2022	262
31	Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial Shun Lü et al. · The Lancet Oncology	28 Jul 2022	257
32	Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies Zhenduo Shi, Kun Pang, Zhuo‐Xun Wu et al. · Signal Transduction and Targeted Therapy Open access	11 Mar 2023	255
33	Matrix Metalloproteinase-2 and -9 Secreted by Leukemic Cells Increase the Permeability of Blood-Brain Barrier by Disrupting Tight Junction Proteins Saran Feng, Jiannong Cen, Yihong Huang et al. · PLoS ONE Open access	17 Aug 2011	242
34	Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study Yuankai Shi et al. · The Lancet Respiratory Medicine	2 Jun 2022	240
35	O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas Chunhai Fan, W-L Liu, Hua Cao et al. · Cell Death and Disease Open access	24 Oct 2013	225
36	Effect of Intravenous Tirofiban vs Placebo Before Endovascular Thrombectomy on Functional Outcomes in Large Vessel Occlusion Stroke RESCUE BT Trial Investigators et al. · JAMA Open access178 authors	9 Aug 2022	215
37	Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial Shun Lü et al. · The Lancet Respiratory Medicine	5 May 2023	214
38	Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study Zhi Peng et al. · 癌症：英文版 Open access	19 Oct 2021	211
39	Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study Shun Lü et al. · The Lancet Respiratory Medicine	21 Jun 2021	211
40	Meta-analysis of genome-wide association studies in East Asian-ancestry populations identifies four new loci for body mass index Wanqing Wen et al. · Human Molecular Genetics ReviewOpen access109 authors	26 May 2014	204
41	p16 deficiency attenuates intervertebral disc degeneration by adjusting oxidative stress and nucleus pulposus cell cycle Hui Che, Jie Li, You Li et al. · eLife Open access	3 Mar 2020	186
42	Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01) Zhijie Wang et al. · Journal of Clinical Oncology Open access	7 Oct 2022	183
43	First-line serplulimab or placebo plus chemotherapy in PD-L1-positive esophageal squamous cell carcinoma: a randomized, double-blind phase 3 trial Yan Song et al. · Nature Medicine Open access	Feb 2023	181
44	Epidermal growth factor receptor in glioblastoma Hongsheng Xu, Hailiang Zong, Chong Ma et al. · Oncology Letters Open access	22 May 2017	172
45	Cardiovascular diseases: oxidative damage and antioxidant protection. Zhang Py, Xin-Rong Xu, XC Li · PubMed	Oct 2014	170
46	Increased expression of long noncoding RNA TUG1 predicts a poor prognosis of gastric cancer and regulates cell proliferation by epigenetically silencing of p57 Erbao Zhang, Xuezhi He, Dandan Yin et al. · Cell Death and Disease Open access	25 Feb 2016	167
47	Gastric cancer: somatic genetics as a guide to therapy Xiaoying Zhang, Pei-Ying Zhang · Journal of Medical Genetics	8 Sep 2016	164
48	CXCL11 Correlates With Antitumor Immunity and an Improved Prognosis in Colon Cancer Yingying Cao, Nanlin Jiao, Tiantian Sun et al. · Frontiers in Cell and Developmental Biology Open access	11 Mar 2021	163
49	Circular RNA hsa_circRNA_103809 promotes lung cancer progression via facilitating ZNF121-dependent MYC expression by sequestering miR-4302 Wei Liu, Weiming Ma, Yuan Yuan et al. · Biochemical and Biophysical Research Communications	26 Apr 2018	163
50	The lncRNA Malat1 regulates microvascular function after myocardial infarction in mice via miR-26b-5p/Mfn1 axis-mediated mitochondrial dynamics Yuqiong Chen, Li Su, Yan Zhang et al. · Redox Biology Open access	23 Feb 2021	162

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.